ロード中...
Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis
Focal segmental glomerulosclerosis (FSGS) is a prevalent glomerular disease characterized by proteinuria, progression to end stage renal disease and recurrence of proteinuria after kidney transplantation in approximately one third of patients. It has been suggested that rituximab might treat recurre...
保存先:
| 主要な著者: | , , , , , , , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3719858/ https://ncbi.nlm.nih.gov/pubmed/21632984 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.3002231 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|